Last updated: 16 July 2019 at 5:58am EST

John A Kraeutler Net Worth




The estimated Net Worth of John A Kraeutler is at least $11.7 million dollars as of 24 August 2017. John Kraeutler owns over 7,000 units of Meridian Bioscience stock worth over $11,727,463 and over the last 21 years John sold VIVO stock worth over $0.

John Kraeutler VIVO stock SEC Form 4 insiders trading

John has made over 11 trades of the Meridian Bioscience stock since 2011, according to the Form 4 filled with the SEC. Most recently John bought 7,000 units of VIVO stock worth $95,690 on 24 August 2017.

The largest trade John's ever made was exercising 48,820 units of Meridian Bioscience stock on 12 September 2011 worth over $102,034. On average, John trades about 2,610 units every 33 days since 2003. As of 24 August 2017 John still owns at least 345,230 units of Meridian Bioscience stock.

You can see the complete history of John Kraeutler stock trades at the bottom of the page.



What's John Kraeutler's mailing address?

John's mailing address filed with the SEC is 3471 RIVER HILLS DRIVE, , CINCINNATI, OH, 45244.

Insiders trading at Meridian Bioscience

Over the last 22 years, insiders at Meridian Bioscience have traded over $8,089,514 worth of Meridian Bioscience stock and bought 228,244 units worth $3,053,655 . The most active insiders traders include Richard Eberly, John P. Kenny et John A Kraeutler. On average, Meridian Bioscience executives and independent directors trade stock every 41 days with the average trade being worth of $424,761. The most recent stock trade was executed by James M. Anderson on 6 January 2023, trading 8,500 units of VIVO stock currently worth $173,230.



What does Meridian Bioscience do?

Meridian Bioscience Inc. is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic products.The company is dedicated to developing and delivering better solutions that give answers with speed, accuracy and simplicity that are redefining the possibilities of life from discovery to diagnosis. Through discovery and development, Meridian provides critical life science raw materials used in immunological and molecular tests for human, animal, plant, and environmental applications. Through diagnosis, Meridian provides diagnostic solutions in areas including gastrointestinal and upper respiratory infections and blood lead level testing. The company builds relationships and provide solutions to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers, and biotech companies in more than 70 countries around the world.



What does Meridian Bioscience's logo look like?

Meridian Bioscience Inc. logo

Complete history of John Kraeutler stock trades at Meridian Bioscience

Date
#
Société
Initié
Trans.
Transaction
Actions Prix par action Prix ​​total Actions après Source
24 Aug 2017 John A Kraeutler
Président et PDG
Acheter 7,000 $13.67 $95,690
24 Aug 2017
345,230
4 Nov 2016 John A Kraeutler
Président et PDG
Acheter 5,000 $16.13 $80,650
4 Nov 2016
316,683
6 Nov 2015 John A Kraeutler
Président et PDG
Exercice d'option 15,750 $14.01 $220,658
6 Nov 2015
339,511
18 Nov 2014 John A Kraeutler
Président et PDG
Exercice d'option 10,500 $7.28 $76,440
18 Nov 2014
284,261
11 Nov 2013 John A Kraeutler
Président et PDG
Exercice d'option 5,250 $25.23 $132,458
11 Nov 2013
275,968
1 May 2013 John A Kraeutler
Président et PDG
Acheter 5,000 $19.63 $98,150
1 May 2013
225,718
21 Sep 2011 John A Kraeutler
Président et PDG
Exercice d'option 2,813 $2.09 $5,879
21 Sep 2011
198,073
14 Sep 2011 John A Kraeutler
Président et PDG
Exercice d'option 23,070 $2.09 $48,216
14 Sep 2011
218,330
12 Sep 2011 John A Kraeutler
Président et PDG
Exercice d'option 48,820 $2.09 $102,034
12 Sep 2011
219,080
7 Sep 2011 John A Kraeutler
Président et PDG
Exercice d'option 22,156 $2.09 $46,306
7 Sep 2011
217,416
31 Aug 2011 John A Kraeutler
Président et PDG
Exercice d'option 26,892 $2.09 $56,204
31 Aug 2011
222,152


Meridian Bioscience executives and stock owners

Meridian Bioscience executives and other stock owners filed with the SEC include: